Coagulation Market Research Reports & Industry Analysis
Coagulation factors have been implicated as independent factors in the development of myocardial infarction, stroke and deep vein thrombosis in some patients. With the increasing incidence of cardiovascular diseases, this discovery has brought what was a rather lackluster discipline into the limelight. The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.
Demand for rapid decentralized coagulation testing is increasing. The number of patients needing coagulation testing is growing. More patients are using anticoagulants following implantation of mechanical heart valves or after atrial fibrillation. More recently patients are using antithrombotic agents after, or to prevent, deep venous thrombosis, arterial or pulmonary embolism, stroke, angina pectoris, and myocardial infarction. There is also increasing pressure to return results to clinicians rapidly so that anticoagulant therapy can be adjusted.
Coagulation Industry Research & Market Reports
-
2022-2026 Serbia Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 South Korea Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood ... Read More
-
2022-2026 Norway Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 Oman Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 Philippines Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 United Arab Emirates Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: ... Read More
-
2022-2026 Nicaragua Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 Nigeria Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
2022-2026 Switzerland Diagnostics Market: Supplier Shares, Strategies, and Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2021 supplier shares, strategies, as well as 2021-2026 volume and sales forecasts for 500 tests within the following market segments: Blood Banking ... Read More
-
Life Science Reagents Market (Product: Chromatography Reagents, Molecular Diagnostics Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell & Tissue Culture Reagents, Hematology & Hemostasis Reagents, Microbiology Reagents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Size, Share, Growth, Trends, and Forecast, 2022-2031 Life Science Reagents Market – Scope of Report TMR’s report on the global life science reagents market studies the past as well as the current growth trends and ... Read More
-
Hemophilia Treatment Market By Type (Hemophilia A, Hemophilia B), By Drug Therapy (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... global hemophilia treatment market was valued at $12,764.8 million in 2021, and is projected to reach $26,905.2 million by 2031, registering a CAGR of 7.5% from 2022 to 2031. Hemophilia is usually an inherited bleeding ... Read More
-
2022 Global Forecast for Antithrombin Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027
... expected to reach US$ 44034 million by the end of 2027, with a CAGR of 7.63% between 2021 and 2027. Global Blood Plasma Fractionation Scope and Market Size The global Blood Plasma Fractionation market is ... Read More
-
Europe Heparin Market, By Product Type (Low Molecular Weight Heparin, Unfractionated Heparin, Ultra Low Molecular Weight Heparin), By End User (Hospitals, Blood and Stem Cell Bank, Others (Laboratories, Acute Care Centers)), and By Region (North America,
... America, Latin America, Europe, Asia Pacific, Middle East & Africa ) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Heparin is obtained naturally from mucosal tissues of slaughtered meat animals such as porcine ... Read More
-
Hemophilia Treatment Market, by Product Type (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Antifibrinolytic Agents, and Desmopressin), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Onl
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hemophilia, a factor VIII deficiency, is a genetic disorder that is caused by the absence of the ... Read More
-
The 2023-2028 World Outlook for Fibrinogen Concentrates
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Human Fibrinogen
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Peptides and Heparin for Diabetes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Hemostasis Analyzers
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Heparin Anticoagulants
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Unfractionated Heparin
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Antithrombin
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2023-2028 World Outlook for Hemostasis and Tissue Sealing Agents
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Coagulation Analysers
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Hematology and Coagulation Instruments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More